A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.

Wu, Peng; Zhang, Zhihui; Yuan, Yongliang; Zhang, Chaoqi; Zhang, Guochao; Xue, Liyan; Yang, Haijun; Wang, Le; Zheng, Xiaoli; Zhang, Yonglei; Yuan, Yufen; Lei, Ruixue; Yang, Zhaoyang; Zheng, Bo; Xue, Qi; Sun, Nan; He, Jie

Wu, Peng; Zhang, Zhihui; Yuan, Yongliang; Zhang, Chaoqi; Zhang, Guochao; Xue, Liyan; Yang, Haijun; Wang, Le; Zheng, Xiaoli; Zhang, Yonglei; Yuan, Yufen; Lei, Ruixue; Yang, Zhaoyang; Zheng, Bo; Xue, Qi; Sun, Nan; He, Jie.

Affiliation

Wu P; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China Department of Pharmacology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China Department of Pathology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col

Int J Surg ; 107: 106960, 2022 Nov.

Article in En | MEDLINE | ID: mdl-36257585

Subject(s)
Key words

Esophageal squamous cell carcinoma; Immune microenvironment; Neoadjuvant chemoradiotherapy; Prognosis prediction; Therapeutic response

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / RNA, Long Noncoding / Esophageal Squamous Cell Carcinoma Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Surg Year: 2022 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google